Literature DB >> 25269460

Androprostamines A and B, the new anti-prostate cancer agents produced by Streptomyces sp. MK932-CF8.

Yohko Yamazaki1, Tetsuya Someno1, Masayuki Igarashi2, Naoko Kinoshita2, Masaki Hatano2, Manabu Kawada1, Isao Momose1, Akio Nomoto3.   

Abstract

Androgen receptor (AR) is a validated target in all clinical states of prostate cancer. Androprostamines A and B, the new inhibitors of androgen receptor, were isolated from Streptomyces sp. MK932-CF8. Their structures were determined by the spectroscopic analysis, degradation studies and synthesis. Androprostamines showed potent inhibitory effect against androgen-dependent growth of human prostate cancer cells without cytotoxicity and repressed the androgen-induced expression of AR-regulated genes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25269460     DOI: 10.1038/ja.2014.135

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  18 in total

1.  Resormycin, a novel herbicidal and antifungal antibiotic produced by a strain of Streptomyces platensis. I. Taxonomy, production, isolation and biological properties.

Authors:  M Igarashi; N Kinoshita; T Ikeda; M Kameda; M Hamada; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1997-12       Impact factor: 2.649

Review 2.  Basic science aspects of prostate cancer.

Authors:  T J Dorkin; D E Neal
Journal:  Semin Cancer Biol       Date:  1997-02       Impact factor: 15.707

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

4.  Resormycin, a novel herbicidal and antifungal antibiotic produced by a strain of Streptomyces platensis. II. Structure elucidation of resormycin.

Authors:  M Igarashi; H Nakamura; H Naganawa; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1997-12       Impact factor: 2.649

Review 5.  Molecular genetics of prostate cancer: new prospects for old challenges.

Authors:  Michael M Shen; Cory Abate-Shen
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

6.  Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.

Authors:  P Koivisto; J Kononen; C Palmberg; T Tammela; E Hyytinen; J Isola; J Trapman; K Cleutjens; A Noordzij; T Visakorpi; O P Kallioniemi
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

Review 7.  Androgen receptor antagonists in castration-resistant prostate cancer.

Authors:  Dana Rathkopf; Howard I Scher
Journal:  Cancer J       Date:  2013 Jan-Feb       Impact factor: 3.360

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

View more
  1 in total

Review 1.  Endophytic bacteria: a new source of bioactive compounds.

Authors:  Monika Singh; Ajay Kumar; Ritu Singh; Kapil Deo Pandey
Journal:  3 Biotech       Date:  2017-09-14       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.